ATP2A2 and dentin dysplasia: Given the cutaneous pathology of DD is limited to the epidermis, we used CRISPR/Cas9 to ablate the ATP2A2 gene in keratinocytes (24), which can be grown into a fully stratified epidermis within an organotypic model (22).